Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now.
News & Analysis: Medtronic
Keep your eyes on these three hot diabetes stocks this month.
MDT earnings call for the period ending January 25, 2019.
Despite some crosscurrents in the overall market, earnings remained generally favorable.
Emerging market growth and new products on the way suggest years of steady dividend raises ahead.
Find out why these stocks missed out on the market rally.
These medtech giants rule the industry. But are any of them great picks for long-term investors?
MDT earnings call for the period ending October 31, 2018.
The company's financial statements took a big step back during the quarter, but all eyes are on the pending Medtronic buyout.
The robotic-assisted spinal surgery specialist is being acquired by Medtronic. Here's what investors need to know.